B-cell receptor and T-cell receptor recognizing H5 hemagglutinin epitopes (H5-specific BCR/TCR)

B-cell receptors (BCRs) and T-cell receptors (TCRs) that specifically recognize epitopes on the H5 hemagglutinin (HA) protein are the primary mediators of the adaptive immune response against H5N1 avian influenza. BCRs on the surface of B cells bind directly to the H5 HA protein, initiating B-cell activation and the subsequent production of neutralizing antibodies that prevent viral attachment and entry into host cells [1]. TCRs recognize H5 HA-derived peptides presented by major histocompatibility complex (MHC) molecules on the surface of infected cells or antigen-presenting cells, orchestrating cellular immunity and providing essential help for antibody production [2]. These receptors are the functional targets of H5N1 vaccines, which are designed to expand the repertoire of H5-specific memory cells to provide protection against future exposure [3]. Therapeutic research also focuses on identifying broadly neutralizing antibodies that target conserved epitopes within the H5 HA stem, which can be used as passive immunotherapy [4]. Understanding the structural interaction between these receptors and H5 epitopes is vital for the development of next-generation vaccines capable of addressing the high mutation rate and pandemic potential of H5 influenza viruses [5].

Other names

H5-specific antigen receptorsH5 hemagglutinin-reactive receptorsH5N1-specific BCRs and TCRsHemagglutinin H5-reactive lymphocytes

Vaccines act as antigenic stimulants to trigger the activation, proliferation, and differentiation of B and T cells expressing these receptors, leading to immunological memory. Monoclonal antibodies function as exogenous, high-affinity analogs of the B-cell receptor to neutralize the H5 virus.